Fig. 1: Expression and pathway analyses.
From: Machine learning prediction for AML based on 3D genome selected circRNA
A circRNA-by-sample expression profiles. AML samples are labeled in yellow, while healthy controls are labeled in blue in the top annotation row. B The Spearman correlation coefficient distribution of 9587 circRNAs and AML disease status across samples. C The volcano plot for identification of differentially expressed circRNAs. D The most significantly enriched pathways from Gene Ontology enrichment analysis.
